First Turn Management, LLC Quant / Systematic

CIK: 0001993440 · Show all filings

Period: Q3 2025 (← Previous) (Next →)

Filing Date: Nov 14, 2025

Total Value ($000): $665,991 (100.0% shares, 0.0% debt)

Holdings (29)

INSM INSMED INC 6.9%
Value ($000) $46,051 Shares 319,773 Est. Cost $48.11 Unrealized +154.6%
MIRM MIRUM PHARMACEUTICALS INC 6.3%
Value ($000) $41,828 Shares 570,569 Est. Cost $33.08 Unrealized +92.2%
UTHR UNITED THERAPEUTICS CORP DEL 5.4%
Value ($000) $35,766 Shares 85,318 Est. Cost $336.31 Unrealized 0.0%
MERUS N V 5.3%
Value ($000) $35,026 Shares 372,022 Est. Cost $61.42 Unrealized
NUVL NUVALENT INC 5.1%
Value ($000) $34,138 Shares 394,754 Est. Cost $71.10 Unrealized +11.2%
XENE XENON PHARMACEUTICALS INC 4.8%
Value ($000) $32,110 Shares 799,743 Est. Cost $37.92 Unrealized -7.1%
BBIO BRIDGEBIO PHARMA INC 4.6%
Value ($000) $30,631 Shares 589,729 Est. Cost $29.85 Unrealized +63.4%
RVMD REVOLUTION MEDICINES INC 4.5%
Value ($000) $30,030 Shares 643,050 Est. Cost $45.05 Unrealized -13.1%
ASND ASCENDIS PHARMA A/S 4.4%
Value ($000) $29,084 Shares 146,291 Est. Cost $144.94 Unrealized
ARGX ARGENX SE 4.3%
Value ($000) $28,593 Shares 38,767 Est. Cost $388.36 Unrealized
IRON DISC MEDICINE INC 3.9%
Value ($000) $26,280 Shares 397,693 Est. Cost $50.06 Unrealized +18.8%
ORIC ORIC PHARMACEUTICALS INC 3.9%
Value ($000) $25,914 Shares 2,159,474 Est. Cost $10.42 Unrealized +1.0%
ACLX ARCELLX INC 3.9%
Value ($000) $25,757 Shares 313,733 Est. Cost $65.31 Unrealized +10.2%
NBIX NEUROCRINE BIOSCIENCES INC 3.8%
Value ($000) $25,535 Shares 181,897 Est. Cost $135.50 Unrealized 0.0%
ABVX ABIVAX SA 3.7%
Value ($000) $24,776 Shares 291,820 Est. Cost $84.90 Unrealized
NAMS NEWAMSTERDAM PHARMA COMPANY 3.1%
Value ($000) $20,391 Shares 716,971 Est. Cost $19.81 Unrealized +21.0%
AKERO THERAPEUTICS INC 2.8%
Value ($000) $18,850 Shares 397,010 Est. Cost $49.18 Unrealized
AXSM AXSOME THERAPEUTICS INC 2.8%
Value ($000) $18,535 Shares 152,614 Est. Cost $77.83 Unrealized +44.7%
ELVN ENLIVEN THERAPEUTICS INC 2.4%
Value ($000) $16,036 Shares 783,411 Est. Cost $21.05 Unrealized -4.2%
APGE APOGEE THERAPEUTICS INC 2.4%
Value ($000) $16,004 Shares 402,811 Est. Cost $45.46 Unrealized -16.0%
KYMR KYMERA THERAPEUTICS INC 2.4%
Value ($000) $15,719 Shares 277,726 Est. Cost $45.10 Unrealized 0.0%
JANX JANUX THERAPEUTICS INC 2.3%
Value ($000) $15,634 Shares 639,699 Est. Cost $42.49 Unrealized -42.7%
ROIV ROIVANT SCIENCES LTD 2.2%
Value ($000) $14,520 Shares 959,703 Est. Cost $12.38 Unrealized 0.0%
CYTK CYTOKINETICS INC 2.1%
Value ($000) $14,004 Shares 254,795 Est. Cost $41.20 Unrealized 0.0%
NTRA NATERA INC 2.0%
Value ($000) $13,018 Shares 80,875 Est. Cost $128.20 Unrealized +23.4%
ADMA ADMA BIOLOGICS INC 1.8%
Value ($000) $11,855 Shares 808,673 Est. Cost $17.93 Unrealized -4.4%
VERA VERA THERAPEUTICS INC 1.5%
Value ($000) $10,303 Shares 354,529 Est. Cost $35.85 Unrealized -35.5%
HROW HARROW INC 1.2%
Value ($000) $7,720 Shares 160,234 Est. Cost $32.60 Unrealized +15.6%
MLTX MOONLAKE IMMUNOTHERAPEUTICS 0.3%
Value ($000) $1,883 Shares 262,643 Est. Cost $52.12 Unrealized 0.0%